The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for the Fiscal Year (FY) 2023 for the Provider’s Clinical Support System – Medications for Opioid Use Disorder Cooperative Agreement (PCSS-MOUD) program. The purpose of this program is to provide training, guidance, and mentoring on the use of Medications for Opioid Use Disorder (MOUD). It is intended to enhance the capacity of healthcare and counseling professionals to identify and treat opioid use disorder (OUD). Award recipients will be expected to develop discipline-specific and multidisciplinary curricula for practitioners, provide training on use of MOUD and provide ongoing mentoring, consultation, and technical assistance to foster knowledge adoption and treatment of OUD. With this program, SAMHSA aims to expand access to treatment of OUD by increasing the number of healthcare professionals that provide MOUD in their setting, provide training, coaching, consultation, and other support services for a wide range of treatment providers and improve healthcare and OUD treatment outcomes and decrease overdose death through use of MOUD.

Eligible applicants are professional associations authorized under Section 1263 of the Consolidated Appropriations Act, 2023 to carry out substance use disorder training of practitioners seeking or renewing registration from the Drug Enforcement Administration (DEA).